Avondale Wealth Management Abb Vie Inc. Transaction History

Avondale Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 11, 2022	SELL	$107.43 - $135.93 $4,297 - $5,437	-40 Closed	0 $0
Q3 2020 Oct 15, 2020	SELL	$85.91 - $100.83 $3,436 - $4,033	-40 Reduced 50.0%	40 $4,000
Q1 2019 Apr 22, 2019	SELL	$77.14 - $90.79 $1,697 - $1,997	-22 Reduced 21.57%	80 $6,000
Q4 2018 Jan 23, 2019	BUY	$77.85 - $96.01 $1,712 - $2,112	22 Added 27.5%	102 $9,000
Q4 2017 Apr 27, 2018	BUY	$89.56 - $98.21 $7,164 - $7,856	80	80 $8,000

3,767

1.28B

13M

9.83M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $360B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Avondale Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Avondale Wealth Management with notifications on news.